Heritage Insurance Holdings, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Heritage Insurance Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $215.32M | Mar 19, 2026 |
| FY2025 | Sep 30, 2025 | $212.46M | Mar 19, 2026 |
| FY2025 | Jun 30, 2025 | $208.04M | Mar 19, 2026 |
| FY2025 | Mar 31, 2025 | $211.52M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $210.26M | Mar 19, 2026 |
| FY2025 | Sep 30, 2024 | $211.85M | Mar 19, 2026 |
| FY2025 | Jun 30, 2024 | $203.57M | Mar 19, 2026 |
| FY2025 | Mar 31, 2024 | $191.30M | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | $186.96M | Mar 13, 2025 |
| FY2024 | Sep 30, 2023 | $186.30M | Mar 13, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $66.68M | Mar 19, 2026 |
| FY2025 | Sep 30, 2025 | $50.42M | Mar 19, 2026 |
| FY2025 | Jun 30, 2025 | $48.02M | Mar 19, 2026 |
| FY2025 | Mar 31, 2025 | $30.47M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $20.29M | Mar 19, 2026 |
| FY2025 | Sep 30, 2024 | $8.15M | Mar 19, 2026 |
| FY2025 | Jun 30, 2024 | $18.87M | Mar 19, 2026 |
| FY2025 | Mar 31, 2024 | $14.23M | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | $30.94M | Mar 13, 2025 |
| FY2024 | Sep 30, 2023 | ($7.42M) | Mar 13, 2025 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $89.68M | Mar 19, 2026 |
| FY2025 | Sep 30, 2025 | $70.17M | Mar 19, 2026 |
| FY2025 | Jun 30, 2025 | $64.87M | Mar 19, 2026 |
| FY2025 | Mar 31, 2025 | $42.44M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $31.52M | Mar 19, 2026 |
| FY2025 | Sep 30, 2024 | $11.75M | Mar 19, 2026 |
| FY2025 | Jun 30, 2024 | $27.64M | Mar 19, 2026 |
| FY2025 | Mar 31, 2024 | $22.70M | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | $36.17M | Mar 13, 2025 |
| FY2024 | Sep 30, 2023 | ($9.44M) | Mar 13, 2025 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $92.97M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $85.14M | Mar 19, 2026 |
| FY2025 | Dec 31, 2023 | $77.78M | Mar 19, 2026 |
| FY2024 | Dec 31, 2022 | $70.40M | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | $65.79M | Mar 13, 2024 |
| FY2022 | Dec 31, 2020 | $81.54M | Mar 13, 2023 |
| FY2021 | Dec 31, 2019 | $80.54M | Mar 14, 2022 |
| FY2020 | Dec 31, 2018 | $88.54M | Mar 9, 2021 |
| FY2019 | Dec 31, 2017 | $71.71M | Mar 10, 2020 |
| FY2018 | Dec 31, 2016 | $58.91M | Mar 12, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $182.24M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $87.10M | Mar 19, 2026 |
| FY2025 | Dec 31, 2023 | $70.42M | Mar 19, 2026 |
| FY2024 | Dec 31, 2022 | ($34.26M) | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | $60.13M | Mar 13, 2024 |
| FY2022 | Dec 31, 2020 | $170.21M | Mar 13, 2023 |
| FY2021 | Dec 31, 2019 | $119.66M | Mar 14, 2022 |
| FY2020 | Dec 31, 2018 | $96.34M | Mar 9, 2021 |
| FY2019 | Dec 31, 2017 | $7.49M | Mar 10, 2020 |
| FY2018 | Dec 31, 2016 | $82.96M | Mar 12, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.07M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $8.23M | Mar 19, 2026 |
| FY2025 | Dec 31, 2023 | $9.89M | Mar 19, 2026 |
| FY2024 | Dec 31, 2022 | $8.56M | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | $1.01M | Mar 13, 2024 |
| FY2022 | Dec 31, 2020 | $755.0K | Mar 13, 2023 |
| FY2021 | Dec 31, 2019 | $4.98M | Mar 14, 2022 |
| FY2020 | Dec 31, 2018 | $2.28M | Mar 9, 2021 |
| FY2019 | Dec 31, 2017 | $385.0K | Mar 10, 2020 |
| FY2018 | Dec 31, 2016 | $1.62M | Mar 12, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.20B | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $2.47B | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | $2.12B | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $2.39B | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $1.98B | Mar 13, 2023 |
| FY2021 | Dec 31, 2020 | $2.09B | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $1.94B | Mar 9, 2021 |
| FY2019 | Dec 31, 2018 | $1.77B | Mar 10, 2020 |
| FY2018 | Dec 31, 2017 | $1.77B | Mar 12, 2019 |
| FY2017 | Dec 31, 2016 | $1.03B | Mar 15, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.69B | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $2.18B | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | $1.90B | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $2.26B | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $1.64B | Mar 13, 2023 |
| FY2021 | Dec 31, 2020 | $1.65B | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $1.49B | Mar 9, 2021 |
| FY2019 | Dec 31, 2018 | $1.34B | Mar 10, 2020 |
| FY2018 | Dec 31, 2017 | $1.39B | Mar 12, 2019 |
| FY2017 | Dec 31, 2016 | $675.29M | Mar 15, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $505.25M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $290.80M | Mar 19, 2026 |
| FY2025 | Dec 31, 2023 | $220.28M | Mar 19, 2026 |
| FY2025 | Dec 31, 2022 | $131.04M | Mar 19, 2026 |
| FY2024 | Dec 31, 2021 | $343.05M | Mar 13, 2025 |
| FY2023 | Dec 31, 2020 | $442.34M | Mar 13, 2024 |
| FY2022 | Dec 31, 2019 | $448.80M | Mar 13, 2023 |
| FY2021 | Dec 31, 2018 | $425.33M | Mar 14, 2022 |
| FY2020 | Dec 31, 2017 | $379.82M | Mar 9, 2021 |
| FY2019 | Dec 31, 2016 | $357.96M | Mar 10, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $0 | Mar 13, 2023 |
| FY2022 | Dec 31, 2021 | $91.96M | Mar 13, 2023 |
| FY2021 | Dec 31, 2020 | $152.46M | Mar 14, 2022 |
| FY2022 | Dec 31, 2019 | $152.46M | Mar 13, 2023 |
| FY2020 | Dec 31, 2018 | $152.46M | Mar 9, 2021 |
| FY2019 | Dec 31, 2017 | $152.46M | Mar 10, 2020 |
| FY2018 | Dec 31, 2016 | $46.45M | Mar 12, 2019 |
| FY2017 | Dec 31, 2015 | $8.03M | Mar 15, 2018 |
| FY2016 | Dec 31, 2014 | $2.35M | Mar 15, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $283.25M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $87.66M | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | $26.12M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | ($19.19M) | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $138.38M | Mar 13, 2023 |
| FY2021 | Dec 31, 2020 | $219.78M | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $217.27M | Mar 9, 2021 |
| FY2019 | Dec 31, 2018 | $195.75M | Mar 10, 2020 |
| FY2018 | Dec 31, 2017 | $175.23M | Mar 12, 2019 |
| FY2017 | Dec 31, 2016 | $182.81M | Mar 15, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $559.27M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $452.67M | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | $463.64M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $280.88M | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $359.34M | Mar 13, 2023 |
| FY2021 | Dec 31, 2020 | $440.96M | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $268.35M | Mar 9, 2021 |
| FY2019 | Dec 31, 2018 | $250.12M | Mar 10, 2020 |
| FY2018 | Dec 31, 2017 | $153.70M | Mar 12, 2019 |
| FY2017 | Dec 31, 2016 | $105.82M | Mar 15, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $78.43M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $116.32M | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | $119.73M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $128.94M | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $120.76M | Mar 13, 2023 |
| FY2021 | Dec 31, 2020 | $121.00M | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $129.25M | Mar 9, 2021 |
| FY2019 | Dec 31, 2018 | $148.79M | Mar 10, 2020 |
| FY2018 | Dec 31, 2017 | $184.41M | Mar 12, 2019 |
| FY2017 | Dec 31, 2016 | $72.91M | Mar 15, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Mar 19, 2026 |
| FY2025 | Sep 30, 2025 | 1 | Mar 19, 2026 |
| FY2025 | Jun 30, 2025 | 1 | Mar 19, 2026 |
| FY2025 | Mar 31, 2025 | 0 | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 19, 2026 |
| FY2025 | Sep 30, 2024 | 0 | Mar 19, 2026 |
| FY2025 | Jun 30, 2024 | 0 | Mar 19, 2026 |
| FY2025 | Mar 31, 2024 | 0 | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | 1 | Mar 13, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Mar 13, 2025 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Mar 19, 2026 |
| FY2025 | Sep 30, 2025 | 1 | Mar 19, 2026 |
| FY2025 | Jun 30, 2025 | 1 | Mar 19, 2026 |
| FY2025 | Mar 31, 2025 | 0 | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 19, 2026 |
| FY2025 | Sep 30, 2024 | 0 | Mar 19, 2026 |
| FY2025 | Jun 30, 2024 | 0 | Mar 19, 2026 |
| FY2025 | Mar 31, 2024 | 0 | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | 1 | Mar 13, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Mar 13, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 30.83M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | 30.61M | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | 30.22M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | 25.54M | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | 26.75M | Mar 13, 2023 |
| FY2021 | Dec 31, 2020 | 27.75M | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | 28.65M | Mar 9, 2021 |
| FY2019 | Dec 31, 2018 | 29.48M | Mar 10, 2020 |
| FY2018 | Dec 31, 2017 | 25.89M | Mar 12, 2019 |
| FY2017 | Dec 31, 2016 | 28.84M | Mar 15, 2018 |